Transpire Bio expands headquarters in Weston, adding 6,600 square feet. New executives join, including Stuart Loesch and Todd ...

(Reuters) -The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Lancaster County projects – 16 of them – were awarded a total of $35.617 million in the most recent round of grants announced ...

Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S. drugmaker's ...

Drugmaker GSK saw a sharp drop in revenue from its blockbuster Arexvy vaccine in the third quarter, dampening overall sales growth. Sales of the jab for respiratory syncytial virus (RSV ...

South Africa's Shoprite Holdings and Mr Price have all sold off their shares, while multinational companies like PZ Cussons and GSK have also announced their exits from Nigeria. Legit.ng earlier ...

Shocking! Lawyer rams Mercedes car into Kachori shop in Delhi, Six injured In a shocking incident, six people were injured after a lawyer rammed his speeding Mercedes car into a Kachori shop in ...

GSK said it is mak­ing its largest man­u­fac­tur­ing in­vest­ment in the US yet, al­lo­cat­ing $800 mil­lion to up­grade its vac­cine pro­duc­tion site in Penn­syl­va­nia. … ...

Is modesty the new mode at Macquarie? It’s certainly the word that comes to mind when gazing upon the boardroom of Macquarie’s new global headquarters in Sydney. Not one piece of art hangs on ...

Construction of AstraZeneca’s new global and R&D headquarters in Cambridge should have been completed last autumn – but builders are struggling to meet a revised deadline of May 2019.

GSK has made its largest-ever single manufacturing investment in the US. Image credit: Shutterstock/ Golden Shrimp. Following outlays for sites in the UK and Belgium earlier this year, GSK is planning ...